Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Abstract Text:

    robert b couchRobert B Couch,patricia winokurPatricia Winokur,rebecca bradyRebecca Brady,robert belsheRobert Belshe,wilbur h chenWilbur H Chen,thomas r cateThomas R Cate,bryndis sigurdardottirBryndis Sigurdardottir,amy hoeperAmy Hoeper,irene l grahamIrene L Graham,robert edelmanRobert Edelman,fenhua heFenhua He,diane ninoDiane Nino,jose capellanJose Capellan,frederick l rubenFrederick L Ruben,robert b couchRobert B Couch,patricia winokurPatricia Winokur,rebecca bradyRebecca Brady,robert belsheRobert Belshe,wilbur h chenWilbur H Chen,thomas r cateThomas R Cate,bryndis sigurdardottirBryndis Sigurdardottir,amy hoeperAmy Hoeper,irene l grahamIrene L Graham,robert edelmanRobert Edelman,fenhua heFenhua He,diane ninoDiane Nino,jose capellanJose Capellan,frederick l rubenFrederick L Ruben,

    To improve immune responses to influenza vaccine, a trivalent inactivated vaccine containing 60 microg of the HA of each component (A/H3N2, A/H1N1, B) was compared to a licensed vaccine containing 15 microg of the HA of each. More local and systemic reactions were reported by subjects given the high dosage but only local pain and myalgias were significantly increased. The high dosage vaccine induced a higher frequency of serum antibody increases (> or =4-fold) in both hemagglutination-inhibiting (HAI) and neutralization tests for all three vaccine viruses in the total group as well as subjects vaccinated and those not vaccinated the previous year. Mean titers of antibody attained, the magnitude of antibody increases and the frequencies of persons with final HAI antibody titers > or =1:32, > or =1:64, and > or =1:128 were all greater for the high dosage group in both serologic tests, for all groups, and for all vaccine viruses. These increased immune responses should provide increased protection against influenza in the elderly.

    Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Publishing Authors By Initials

    rb couchRB Couch,p winokurP Winokur,r bradyR Brady,r belsheR Belshe,wh chenWH Chen,tr cateTR Cate,b sigurdardottirB Sigurdardottir,a hoeperA Hoeper,il grahamIL Graham,r edelmanR Edelman,f heF He,d ninoD Nino,j capellanJ Capellan,fl rubenFL Ruben,rb couchRB Couch,p winokurP Winokur,r bradyR Brady,r belsheR Belshe,wh chenWH Chen,tr cateTR Cate,b sigurdardottirB Sigurdardottir,a hoeperA Hoeper,il grahamIL Graham,r edelmanR Edelman,f heF He,d ninoD Nino,j capellanJ Capellan,fl rubenFL Ruben,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Vaccine

    VOLUME: 25

    Page Numbers: 7656-63

    Journal Abbreviation: Vaccine

    ISSN: 0264-410X

    DAY: 14

    MONTH: 09

    YEAR: 2007

    Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8406899

    Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

    AFFILIATION: Baylor College of Medicine, One Baylor Plaza, MS: BCM280, Houston, TX 77030, United States. ikirk@bcm.edu

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY: United States NIAID

    GRANT: N01-AI-30039

    ACRONYM: AI

    MEDLINETA: Vaccine

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News